An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers

Psychopharmacology

Volumn 198, Issue 1, 2008, Pages 127-139

  Scholey, Andrew B ^a   Tildesley, Nicola T J ^b   Ballard, Clive G ^c   Wesnes, Keith A ^a,b,d   Tasker, Andrea ^e   Perry, Elaine K ^e   Kennedy, David O ^b  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b NORTHUMBRIA UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Cognitive Drug Research Ltd ^*  (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acetylcholine; Age related memory decline; Alzheimer's disease; Attention; Cholinesterase; Cognition; Cognitive decline; Memory; Sage; Salvia

Indexed keywords

PLACEBO; PLANT EXTRACT; SALVIA EXTRACT;

ADULT; AGED; ARTICLE; ATTENTION; CHOLINESTERASE INHIBITION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; MEMORY CONSOLIDATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECALL; SALVIA; TASK PERFORMANCE; WORKING MEMORY;

AGED; AGED, 80 AND OVER; AROUSAL; ATTENTION; CHOLINESTERASE INHIBITORS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PLANT EXTRACTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; READING; SALVIA; SPACE PERCEPTION;

EID: 43049129922     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1101-3     Document Type: Article

References (41)

1. Aggleton JP, Brown WB (1999) Episodic memory, amnesia and the hippocampal-anterior thalamic axis. Behav Brain Sci 22:425-486
2. Akhondzadeh S, Noroozian N, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M (2003) Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28:1-7
3. Bartram T (1998) Bartram's encyclopaedia of herbal medicine. Robinson, London
4. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
5. Gardiner JM, Richardson-Klavehn A (2000) Remembering and knowing. In: Tulving E, Craik FIM (eds) Handbook of memory. Oxford University Press, New York, pp 229-244
6. Herholz K, Weisenbach S, Kalbe E, Diederich NJ, Heiss WD (2005) Cerebral acetylcholine esterase activity in mild cognitive impairment. NeuroReport 8:1431-1434
7. Howes MJR, Perry NSL, Houghton PJ (2003) Plants with traditional uses and activities relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 17:1-18
8. Imanshahidi M, Hosseinzadeh H (2006) The pharmacological effects of salvia species on the central nervous system. Phytother Res 20:427-437
9. Kennedy DO, Scholey AB (2005) The psychopharmacology of European herbs with cognition enhancing properties. Curr Pharm Des 12:4613-4623
10. Kennedy DO, Scholey AB, Wesnes K (2001a) Differential, dose-dependent changes in cognitive performance and mood following acute administration of ginseng to healthy young volunteers. Nutr Neurosci 4:399-412
11. Kennedy DO, Scholey AB, Wesnes KA (2001b) Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci 4:399-412
12. Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KS (2002a) Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav 72:953-964
13. Kennedy DO, Scholey AB, Wesnes KA (2002b) Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav 75:739-751
14. Kennedy DO, Wake G, Savelev S, Tildesley NTJ, Perry EK, Wesnes KS, Scholey AB (2003) Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 28:1871-1881
15. Kennedy DO, Pace S, Haskell C, Okello EJ, Milne A, Scholey AB (2005) Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology 31:845-852
16. Keppel G (1991) Design and analysis. Prentice-Hall, New Jersey
17. Mantle D, Pickering AT, Perry EK (2000) Medicinal plant extracts for the treatment of dementia: a review of their pharmacology, efficacy and tolerability. CNS Drugs 13:201-213
18. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356:2031-2036
19. Miyazawa M, Watanabe H, Kameoka H (1997) Inhibition of acetylcholinesterase activity by monoterpenoids with a p-menthane skeleton. J Agric Food Chem 45:677-679
20. Muir JL (1997) Acetylcholine, aging, and Alzheimer's disease. Pharmacol Biochem Behav 56:687-696
21. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000) Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butylcholinesterase in vitro. Methods Find Exp Clin Pharmacol 22:609-613
22. Perry N, Court G, Bidet N, Court J, Perry E (1996) European herbs with cholinergic activities: potential in dementia therapy. Int J Geriatr Psychiatry 11:1063-1069
23. Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NSL (1999) Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J Pharm Pharmacol 51:527-534
24. Perry N, Howes M, Houghton P, Perry E (2000a) Why sage may be a wise remedy: effects of Salvia on the nervous system. In: Kintzios SE (ed) Sage: the genus Salvia. Harwood, Netherlands, pp 207-223
25. Perry NSL, Houghton PJ, Theobald A, Jenner P, Perry EK (2000b) In-vitro inhibition of erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 53:1347-1356
26. Perry NSL, Houghton PJ, Sampson J, Theobald AE, Hart S, LisBalchin M (2001) In-vitro activities of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol 53:1347-1356
27. Perry NSL, Houghton PJ, Jenner P, Keith A, Perry EK (2002) Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. Phytomedicine 9:48-51
28. Perry NSL, Bollen C, Perry EK, Ballard C (2003) Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 75:651-659
29. Randall DC, Shneerson JM, File SE (2005) Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav 82:133-139
30. Savelev S, Okello E, Perry NSL, Wilkins RM, Perry E (2003) Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil. Biochem Pharmacol Behav 75:661-668
31. Savelev S, Okello EJ, Perry EK (2004) Butyryl and acetylcholinesterase inhibitory activities in essential oils of salvia species and their constituents. Phytotherapy Res 18:315-324
32. Scholey AB (2002) Attention. In: Perry EK, Ashton H, Young AH (eds) Neurochemistry of consciousness. Benjamins, Amsterdam, pp 43-63
33. Scholey AB, Kennedy DO (2002) Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol Clin Exp 17:35-44
34. Scholey AB, Kennedy DO (2004) Cognitive and physiological effects of an "energy drink": an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions. Psychopharmacology 176:320-330
35. Scholey AB, Harper S, Kennedy DO (2001) Cognitive demand and blood glucose. Physiol Behav 73:585-592
36. Scholey A, Kennedy D, Wesnes K (2005) The psychopharmacology of herbal extracts: issues and challenges. Psychopharmacology 179:705-707
37. Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1-58
38. Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Savelev S, Wesnes KA, Scholey AB (2003) Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Biochem Pharmacol Behav 75:669-674
39. Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB (2005) Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav 83:699-709
40. Wesnes K (2003) The cognitive drug research computerised assessment system: application to clinical trials. In: De Deyn P, Thiery E, D'Hooge R (eds) Memory: basic concepts, disorders and treatment. Uitgeverij Acco, Leuven, pp 453-472
41. Wesnes KA, Ward T, McGinty A, Petrini O (2000) The memory enhancing effects of a Ginkgo-biloba/Panax ginseng combination in healthy middle aged volunteers. Psychopharmacology 152:353-361